This study is currently not recruiting participants.

A Placebo-controlled Double-blind Parallel-Group Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease

Study on the Effects of an Investigational Medication on Memory and Thinking in Early Alzheimer's

Not Recruiting
50 years - 90 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this research is to find out if the study drug has a benefit on a person?s cognitive status via a series of specialized cognitive tests. The purpose of this research is also to find out if this study drug is safe and well-tolerated in people with early Alzheimer?s disease.

Detailed description of study

The purpose of this research is to find out if the study drug has a benefit on a person?s cognitive status via a series of specialized cognitive tests. The purpose of this research is also to find out if this study drug is safe and well-tolerated in people with early Alzheimer?s disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Alzheimer's disease
  • Age: 50 years - 90 years
  • Gender: All

This study investigates the effects of an investigational medication on cognitive status in individuals with early Alzheimer's disease. Alzheimer's disease is a condition that affects memory and thinking skills. The study aims to determine if the investigational medication can improve cognitive abilities and assess its safety and tolerability in participants.

Participants will undergo a series of specialized cognitive tests to evaluate the effects of the investigational medication. These tests are designed to measure changes in memory, attention, and other cognitive functions. The study will help understand the medication's impact on cognitive health.

  • Who can participate: Adults aged X to Y with early Alzheimer's disease may be eligible to participate. Specific criteria will determine eligibility.
  • Study details: Participants will take part in memory and thinking tests to see how the investigational medication works. A placebo, an inactive substance that looks like the investigational medication but does not contain any medicine, may be used for comparison.
Updated on 19 Feb 2024. Study ID: 1212010226

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team